Share Email Print

Proceedings Paper

The application of 5-aminolevulinic acid in the treatment of precancerous lesions, skin cancer, and a new approach to the control of therapy
Author(s): Zbigniew Kulas; Elżbieta Bereś - Pawlik; Andrzej Bieniek; Łukasz Matusiak
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The aim of our work was to determine a therapeutic effect of photodynamic therapy (PDT). Twenty five patients with the Bowen's disease, actinic keratosis and basal cell carcinoma (superficial, nodular) were examined. They were treated with photosensitizer - aminolevulinic acid (metabolized in protoporphyrin IX), and the new red light source built of high-power diodes. A new method, based on numerical analysis of fluorescence imaging of tissues, was proposed as a way for controlling therapy.

Paper Details

Date Published: 23 February 2009
PDF: 7 pages
Proc. SPIE 7161, Photonic Therapeutics and Diagnostics V, 716111 (23 February 2009); doi: 10.1117/12.809611
Show Author Affiliations
Zbigniew Kulas, Wroclaw Univ. of Technology (Poland)
Elżbieta Bereś - Pawlik, Wroclaw Univ. of Technology (Poland)
Andrzej Bieniek, Wroclaw Medical Univ. (Poland)
Łukasz Matusiak, Wroclaw Medical Univ. (Poland)

Published in SPIE Proceedings Vol. 7161:
Photonic Therapeutics and Diagnostics V
Henry Hirschberg; Steen J. Madsen; Brian Jet-Fei Wong; Justus F. R. Ilgner; Kenton W. Gregory; Guillermo J. Tearney; Laura Marcu; Reza S. Malek; Nikiforos Kollias; Bernard Choi; Haishan Zeng, Editor(s)

© SPIE. Terms of Use
Back to Top